{"id":153962,"date":"2010-01-08T09:24:39","date_gmt":"2010-01-08T14:24:39","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=57683"},"modified":"2010-01-08T09:24:39","modified_gmt":"2010-01-08T14:24:39","slug":"synta-nabs-25m-in-stock-deal","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/153962","title":{"rendered":"Synta Nabs $25M in Stock Deal"},"content":{"rendered":"\n
Biotech<\/a>, cancer<\/a>, deals<\/a><\/div>\n

\t\tLuke Timmerman wrote:<\/strong><\/p>\n

Synta Pharmaceuticals, the Lexington, MA-based developer of cancer drugs, said today<\/a> it has raised $25 million in a stock offering. The company (NASDAQ: SNTA<\/a>) sold 5.5 million shares at $4.50 apiece—about a 17.6 percent discount from yesterday’s closing price of $5.46. Lazard Capital Markets led the offering and RBC Capital Markets served as a co-manager. The company had $51.7 million in cash and investments at the end of September, according to<\/a> its most recent financial report.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech, cancer, deals Luke Timmerman wrote: Synta Pharmaceuticals, the Lexington, MA-based developer of cancer drugs, said today it has raised $25 million in a stock offering. The company (NASDAQ: SNTA) sold 5.5 million shares at $4.50 apiece—about a 17.6 percent discount from yesterday’s closing price of $5.46. Lazard Capital Markets led the offering and RBC […]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-153962","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/153962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=153962"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/153962\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=153962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=153962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=153962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}